Latest news by search query "core technology covid 19"

Germany Science and Technology World Science Europe Coronavirus Health

03.03.2021 / 00:43

Hinshaw, Shandro to provide provincial COVID-19 update Tuesday afternoon

COVID-19 in the province and “the ongoing work to protect public health.”The chief medical officer of health and minister will be making their comments at 4 p.m. and you can watch them in this story.

Deena Hinshaw Tyler Shandro Alberta Covid Alberta Coronavirus province Covid covid-19 Coronavirus

New research suggests Alberta COVID-19 R value currently too high to lift restrictions

new measures announced on Nov. 24.[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]Kenney said the province’s R value must be below one by Dec.

Alberta Covid Alberta Coronavirus province Covid covid-19 Alberta COVID-19 Alberta Government Coronavirus

pharmaceutical-technology.com

01.09.2020 / 17:41

41%

943

Oxford Biomedica enters Covid-19 vaccine manufacturing deal

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.UK-based gene and cell therapy group Oxford Biomedica has entered a supply agreement with AstraZeneca UK for large-scale production of Covid-19 vaccine candidate, AZD1222. The 18-month supply deal is part of a three-year master supply and development agreement between the companies, which may choose to expand the supply period for an additional 18 months into 2022 and 2023.

Britain covid-19 information vaccine

pharmaceutical-technology.com

31.08.2020 / 12:57

66%

147

Q&A with IQVIA: digital transformation in a post-Covid-19 world

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The pharma industry – and clinical trials in particular – have been significantly disrupted by the Covid-19 pandemic. For example, lockdowns and social distancing have made it all but impossible for many ill patients to visit their trial sites for monitoring and medication.

covid-19 pandemic information patient

pharmaceutical-technology.com

31.08.2020 / 12:57

86%

976

FDA grants EUA for Gilead’s remdesivir to treat Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Gilead Sciences’ Veklury (remdesivir) to treat all hospitalised patients with Covid-19. Previously, the drug received emergency authorisation for treating patients hospitalised with severe form of the disease.

Usa covid-19 information patient

pharmaceutical-technology.com

31.08.2020 / 11:05

40%

493

Sinovac’s Covid-19 vaccine gets emergency use approval in China

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Sinovac Biotech has received emergency use approval for its potential Covid-19 vaccine CoronaVac under a programme in China to vaccinate high-risk groups, according to Reuters citing a person familiar with the matter. The company started developing the inactivated vaccine against Covid-19 in January this year in alliance with academic research institutes in China.

China covid-19 information vaccine

pharmaceutical-technology.com

14.08.2020 / 18:15

55%

672

UNION therapeutics licences drug technology from TFF Pharmaceuticals

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.UNION therapeutics has signed an agreement with TFF Pharmaceuticals for an exclusive global licence to the latter’s Thin Film Freezing (TFF) technology platform used with niclosamide drug. The TFF platform is intended to improve the solubility and absorption of poorly water-soluble drugs, ideal for generating dry powder particles.

covid-19 information Government

pharmaceutical-technology.com

30.07.2020 / 13:03

82%

779

From rare diseases to Covid-19: charting the history of Genomics England

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.In 2003, after 13 years of work and more than £2bn spent, scientists involved in the Human Genome Project mapped the first complete genetic code, or genome, of a human being. This was a huge scientific breakthrough and taught genetics researchers a lot about human genes, the genome and how they interact with health and disease.

covid-19 NHS medicines diseases

pharmaceutical-technology.com

20.07.2020 / 17:17

40%

152

Reimbursement of telemedicine services could continue even after the abatement of COVID-19 pandemic: Poll

The analysis is based on 368 responses received from the readers of Verdict’s Pharmaceutical Technology site between 18 June and 20 July.Consumers of telemedicine services in the US increased to 46% compared to 11% before the COVID-19 pandemic, according to a report from McKinsey and Company, which notes that approximately $250bn in US healthcare spending is expected to shift towards telemedicine after the pandemic ends. Effectiveness compared to in-person visits, security, and reimbursement continues to remain crucial in the future success of telemedicine services.

Usa covid-19 pandemic

pharmaceutical-technology.com

20.07.2020 / 14:43

38%

148

UK enters supply agreement for Pfizer and BioNTech’s Covid-19 vaccine

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The UK Government has signed an agreement with Pfizer and BioNTech for the supply of 30 million doses of the companies’ mRNA-based Covid-19 vaccine candidate, BNT162. Neither company divulged financial details of the deal, but the terms were said to be contingent on the delivery timing and the volume of doses.

Ugur Sahin Britain covid-19 vaccine Government

pharmaceutical-technology.com

20.07.2020 / 12:59

40%

875

Medidata virtual NEXT Q&A: Covid-19 and patient centricity

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Due to the Covid-19 pandemic, life sciences software vendor Medidata recently held its NEXT conference virtually. In her welcoming remarks, executive vice-president and head of product Jackie Kent focused on Medidata’s actions to support its customers during the disruption of the pandemic.

covid-19 pandemic information patient

pharmaceutical-technology.com

20.07.2020 / 11:10

49%

804

Gilead gets Hong Kong conditional approval for remdesivir for Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Gilead Sciences’ Hong Kong unit has received conditional approval from the country’s Pharmacy and Poisons Committee for the use of Veklury (remdesivir) to treat Covid-19. The Committee held an ad-hoc meeting to review the company’s application and speed-up the registration approval of the drug.

Hong Kong city Hong Kong covid-19 Department

pharmaceutical-technology.com

17.07.2020 / 15:33

49%

426

J&J in talks with Japan and Gates Foundation for Covid-19 vaccine

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.US-based Johnson & Johnson (J&J) is in discussions with the Government of Japan, as well as the Bill and Melinda Gates Foundation, regarding allocations of its Covid-19 vaccine candidate. In an interview with Reuters, J&J chief financial officer Joseph Wolk said that the company already agreed to an allocation deal with the US as part of its funding agreement with the US Biomedical Advanced Research and Development Authority (BARDA).

Japan Usa county Gates covid-19 vaccine Government

pharmaceutical-technology.com

17.07.2020 / 13:25

40%

691

Tonix to focus on precision medicine approaches for Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Tonix Pharmaceuticals has signed a research collaboration and option agreement with Columbia University to explore precision medicine approaches for vaccines and therapeutics against Covid-19. The partners will study the immune responses to Covid-19 in healthy volunteers who recovered from the disease or were asymptomatic.

city Columbia covid-19 vaccine medicines

pharmaceutical-technology.com

19.06.2020 / 11:19

46%

756

India’s CDRI gets approval for Phase III trial of Umifenovir to treat Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Central Drug Research Institute (CDRI), a constituent lab of India-based Council of Scientific and Industrial Research (CSIR), has secured approval for carrying out Phase III trial for the use of Umifenovir in the treatment of Covid-19. In this randomised, double-blind, placebo-controlled trial, CDRI will test the efficacy, safety and tolerability of Umifenovir.

China India Russia covid-19 testing patient

pharmaceutical-technology.com

18.06.2020 / 17:47

73%

122

Tonix and Southern Research to study immune responses to Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Tonix Pharmaceuticals has expanded its ongoing partnership with non-profit Southern Research to study T-cell immune responses to SARS-CoV-2, the novel coronavirus that causes Covid-19. The partners formed an alliance in March this year to develop a vaccine against Covid-19 using Tonix’s horsepox vaccine platform.

virus covid-19 information vaccine

pharmaceutical-technology.com

18.06.2020 / 13:09

63%

580

PDS Biotech and Farmacore partner to develop Covid-19 vaccine

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.US-based immunotherapy company PDS Biotechnology has partnered with Brazilian biotechnology firm Farmacore Biotechnology to jointly develop a Covid-19 vaccine. The vaccine candidate, Versamune-CoV-2FC (PDS0204), is based on PDS Biotechnology’s immune-activating Versamune platform, integrating a recombinant fusion protein of SARS-CoV-2 developed by Farmacore to be recognised by the human immune system.

Brazil covid-19 testing vaccine

pharmaceutical-technology.com

18.06.2020 / 11:49

63%

814

Dexamethasone: the first drug to improve survival chances for Covid-19 patients

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.On 16 June, the primary investigators of the UK’s RECOVERY trial announced that the commonly used, low-price corticosteroid dexamethasone has proven to be a potentially life-saving new treatment option for those critically ill with Covid-19 and requiring respiratory support. World Health Organization director-general Dr Tedros Adhanom Ghebreyesus noted: “This is the first treatment to be shown to reduce mortality in patients with Covid-19 requiring oxygen or ventilator support.

Tedros Adhanom Ghebreyesus Britain covid-19 Government Ventilators patient

pharmaceutical-technology.com

02.06.2020 / 14:51

54%

955

Emergent gets $628m Covid-19 vaccine manufacturing contract

Emergent BioSolutions has secured a $628m contract from the US Biomedical Advanced Research and Development Authority (BARDA) for domestic manufacturing of Covid-19 vaccine candidates.

Usa county Camden Baltimore city Rockville covid-19 pandemic innovations vaccine

pharmaceutical-technology.com

02.06.2020 / 13:55

89%

606

Atea closes $215m Series D round to support Covid-19 trials

Boston-based Atea Pharmaceuticals has raised $215m in a Series D financing round. The investment was led by Bain Capital Life Sciences; other new investors that participated in the round include Omega Funds, Rock Springs Capital and Redmile Group. Some of Atea’s existing investors also participated, including Ally Bridge Group and Morningside Ventures.

Usa city Boston county Rock virus covid-19 RNA pandemic

pharmaceutical-technology.com

01.06.2020 / 15:19

77%

179

Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests

South Korea-based Celltrion Group has reported positive results from the preclinical tests of its Covid-19 antibody treatment, which led to a 100-fold decrease in the viral load of SARS-CoV-2.

South Korea covid-19 testing medicines

pharmaceutical-technology.com

01.06.2020 / 10:27

42%

347

Russia grants temporary approval for Avifavir to treat Covid-19

The Ministry of Health of the Russian Federation has granted a temporary registration certificate to Covid-19 treatment, Avifavir, produced by the Russian Direct Investment Fund (RDIF) and ChemRar Group.

Japan Russia state University covid-19 vaccine patient Coronavirus

pharmaceutical-technology.com

19.05.2020 / 15:31

56%

686

J&J signs Covid-19 vaccine manufacturing contract with Vibalogics

Johnson & Johnson (J&J) has signed a deal with contract development and manufacturing organisation (CDMO) Vibalogics for the manufacture of clinical trial material for a Covid-19 vaccine candidate being developed by J&J unit Janssen Pharmaceutical.

Germany virus covid-19 testing vaccine

pharmaceutical-technology.com

19.05.2020 / 10:13

76%

310

Cipla to explore remdesivir multi-drug combination for Covid-19

India-based Cipla has plans to explore the use of multi-drug combination, including Gilead Sciences’ investigational antiviral drug remdesivir, for the treatment of Covid-19 coronavirus infection.

India covid-19 infection patient Coronavirus

pharmaceutical-technology.com

18.05.2020 / 14:39

86%

778

Sorrento’s antibody completely blocks Covid-19 in-vitro

Sorrento Therapeutics has reported that its Covid-19 therapeutic antibody candidate, STI-1499, can completely block the viral infection in-vitro during preclinical studies.

virus covid-19 infection

pharmaceutical-technology.com

18.05.2020 / 14:39

78%

549

UK provides funding support for Covid-19 vaccine programme

The UK Government has committed to providing £84m in funding and manufacturing support to researchers working on Covid-19 vaccine programme, said Business Secretary Alok Sharma.

Alok Sharma Britain city London city Oxford covid-19 innovations vaccine Government

pharmaceutical-technology.com

06.05.2020 / 14:15

86%

131

CSL Behring Australia joins race for Covid-19 therapy development

The Australian subsidiary of CSL Behring is set to develop a plasma-derived therapeutic for the treatment of serious complications in Covid-19 patients.

Australia covid-19 infection donates patient

pharmaceutical-technology.com

24.04.2020 / 14:23

81%

703

J&J selects Emergent BioSolutions for Covid-19 vaccine manufacturing

Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutical has signed an agreement with Emergent BioSolutions for manufacturing services for its lead investigational Covid-19 vaccine candidate.

covid-19 vaccine

pharmaceutical-technology.com

24.04.2020 / 11:17

62%

157

Gilead says leaked Covid-19 trial data of remdesivir inconclusive

Gilead’s remdesivir has failed to show benefit in a clinical trial conducted to treat Covid-19 patients in China, according to data the World Health Organization (WHO) accidentally posted on its website.

China covid-19 death patient

pharmaceutical-technology.com

22.04.2020 / 15:08

38%

614

Real-world evidence the most impactful emerging technology in COVID-19 management: Poll

New-age emerging technologies are projected to have a significant impact on managing the coronavirus pandemic (COVID-19).

covid-19 testing patient

pharmaceutical-technology.com

14.04.2020 / 16:37

83%

252

Sanofi and GSK partner to develop Covid-19 vaccine

Sanofi and GlaxoSmithKline (GSK) have signed a letter of intent for a partnership focused on developing an adjuvanted vaccine for Covid-19.

Usa city Sanofi covid-19 vaccine DNA infection

pharmaceutical-technology.com

14.04.2020 / 15:21

66%

704

AstraZeneca to trial Calquence to treat Covid-19 patients

AstraZeneca is set to conduct a global clinical trial of Calquence (acalabrutinib) to treat cytokine storm that manifests in severely ill Covid-19 patients.

covid-19 death Ventilators patient

pharmaceutical-technology.com

14.04.2020 / 13:13

73%

598

Celltrion identifies antibody candidates against Covid-19

Celltrion Group has completed a neutralisation test and identified the antibody candidates that showed the most promise for neutralising the novel coronavirus, SARS-CoV-2, which causes Covid-19.

covid-19 testing crisis Coronavirus

pharmaceutical-technology.com

13.04.2020 / 18:25

91%

409

Immunomic partners EpiVax and PharmaJet on Covid-19 vaccine

Biotechnology firm Immunomic Therapeutics has partnered with EpiVax and PharmaJet to develop a vaccine candidate against Covid-19 infection.

covid-19 vaccine infection Coronavirus

Sean Penn Volunteers With CORE at COVID-19 Coronavirus Testing Stations in LA

Sean Penn isn’t spending his time at home during Los Angeles’ stay at home order, but instead volunteering at a testing station.

Sean Penn Leila George Los Angeles city Los Angeles covid-19 testing Volunteers Coronavirus

pharmaceutical-technology.com

07.04.2020 / 13:49

76%

360

GSK buys stake in Vir Biotechnology in search of Covid-19 therapies

GlaxoSmithKline (GSK) has agreed to invest $250m in Vir Biotechnology for the research and development (R&D) of antibodies to treat Covid-19 infection.

covid-19 vaccine infection Coronavirus

pharmaceutical-technology.com

03.04.2020 / 17:03

61%

243

FluGen, Bharat Biotech and UW–Madison partner on Covid-19 vaccine

Vaccine development companies FluGen and Bharat Biotech have partnered with the University of Wisconsin–Madison (UWMadison) to develop and evaluate a Covid-19 vaccine candidate, CoroFlu.

state Wisconsin Madison virus covid-19 vaccine Coronavirus

pharmaceutical-technology.com

03.04.2020 / 17:03

87%

914

Different paths to the same destination: screening for Covid-19

Over the course of the current Covid-19 crisis, the importance of reliable, accessible testing to screen for the disease has become increasingly apparent. South Korea, where tests for the disease were made promptly and readily available when the outbreak first hit, has had a drastically lower death rate than counties which have responded less promptly. Only 174 Covid-19 fatalities have been recorded in South Korea out of over 10,000 recorded cases, compared to 2,921 deaths in the UK out of nearly 34,000 recorded cases.

South Korea Britain virus covid-19 testing infection

pharmaceutical-technology.com

03.04.2020 / 17:03

89%

357

Vir Biotechnology and Alnylam expand alliance for Covid-19 drugs

Vir Biotechnology and Alnylam Pharmaceuticals have expanded their multi-target infectious diseases alliance to include up to three targets for SARS-CoV-2, the novel coronavirus that causes Covid-19.

virus covid-19 infection Coronavirus

pharmaceutical-technology.com

03.04.2020 / 17:03

50%

617

Novartis and Incyte to trial Jakavi for Covid-19

Novartis, in alliance with Incyte, has announced plans to evaluate Jakavi (ruxolitinib) in a Phase III clinical trial to treat cytokine storm in patients with severe Covid-19 pneumonia.

Usa Switzerland covid-19 pneumonia infection patient

pharmaceutical-technology.com

03.04.2020 / 15:13

36%

442

Covid-19 impact: Global VC funding activity continues to remain subdued

The number of venture capital (VC) funding announced deals dropped by 22.5% during the week ended 29 March 2020 compared to the previous week, according to GlobalData’s deals database.

China Usa Britain covid-19 outbreak 2020 Coronavirus

pharmaceutical-technology.com

03.04.2020 / 15:13

80%

246

Healthcare sector witnesses growth in deal activity despite Covid-19 concerns

A total of 152 deals were announced in the global healthcare sector, including pharmaceuticals and medical equipment, during the week ended 29 March 2020 according to GlobalData’s deals database.

China Usa Britain covid-19 outbreak 2020

pharmaceutical-technology.com

03.04.2020 / 13:31

92%

380

Covid-19 vaccine candidate yields promising data in mice

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Usa virus covid-19 vaccine medicines

pharmaceutical-technology.com

03.04.2020 / 13:31

49%

152

Amgen and Adaptive Biotechnologies to develop Covid-19 drug

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

virus covid-19 infection medicines

pharmaceutical-technology.com

03.04.2020 / 10:03

59%

686

Apeiron Biologics gets regulatory approvals for Phase II Covid-19 trial

Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct a Phase II clinical trial of APN01 for the treatment of Covid-19.

Austria Germany Denmark virus covid-19 infection patient

pharmaceutical-technology.com

03.04.2020 / 09:03

87%

708

Global confirmed Covid-19 cases exceed one million

The Covid-19 cases have crossed one million globally, with the pandemic being responsible for more than 52,000 deaths so far.

China Usa covid-19 death Coronavirus

pharmaceutical-technology.com

26.03.2020 / 17:39

93%

283

Xencor, Vir Biotechnology sign licensing deal for Covid-19

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

covid-19 president pandemic

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0

Latest news by search query "core technology covid 19"

Related News